← FDA Drug Approvals (Drugs@FDA)

SIMBRINZA

NDA · New Drug Application · Sponsor: ALCON LABS INC · Approved 2013-04-19

Drug application

FDA Application #

NDA204251

Application type

New Drug Application

Brand name

SIMBRINZA

Generic name

BRINZOLAMIDE/BRIMONIDINE TARTRATE

Active ingredients

BRIMONIDINE TARTRATE; BRINZOLAMIDE

Dosage form

SUSPENSION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

ALCON LABS INC

Manufacturer

Alcon Laboratories, Inc.

First approval

2013-04-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown